. The mutation can be (detected) in prospective parents by genetic screening, and in a fetus by prenatal diagnosis. Researchers continue to explore options for treatment. (Potential therapies) involve blocking ganglioside synthesis, using gene therapy to deliver a normal version of the missing enzyme to the brain, or infusing normal blood cells from umbilical cords. All treatments are still considered experimental, and Tay–Sachs is still incurable.